Live News Categoriesequity

Newron Pharmaceuticals S.p.A. (NWRN.SW) News

Follow Newron Pharmaceuticals S.p.A. (NWRN.SW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol NWRN.SW Asset equity Sector Markets 90 days 0 Last 7.8 Updated Jul 03, 2026, 04:10 AM UTC Open live news feed Open NWRN.SW chart & news

L Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment () -- Newron Pharmaceuticals (NWRN.SW) said Thursday it agreed to make changes to the phase 3 Enigma-TRS trial of evenamide as a treatment for schizophrenia to allay concerns of the US Food and Drug Administration. The r REGULATION | Jul 03, 2026, 04:10 AM UTC